El Auto muestreo para el diagnóstico de VPH y vacunación, para la prevención del cáncer de cuello uterino en Ecuador

Authors

  • Bernardo Vega Crespo Universidad de Cuenca
  • Vivian Alejandra Neira Molina Univeridad de Cuenca
  • Andrés Andrade Galarza Univeridad de Cuenca
  • Dayanara Delgado López Universidad de Cuenca
  • Veronique Verhoeven Universidad de Amberes
  • Miguel Rodríguez Jiménez Sociedad de Ginecología y Obstetricia Azuay

Keywords:

vacunación, auto muestreo, VPH

Abstract

Cervical cancer is a disease that can be eliminated through vaccination against the human papillomavirus (HPV), timely detection using high-sensitivity tests, and the monitoring/treatment of cervical pathologies. In Ecuador, cervical cancer is the second leading cause of cancer death in women. Mortality from this cause is related to vaccination and screening coverage at the national level, which still does not meet international standards. This document compiles scientific evidence generated at the national and international levels, aimed at reducing mortality from this disease

Downloads

Download data is not yet available.

Downloads

Published

2024-04-16

Issue

Vol. 42 No. 1 (2024): Revista de la Facultad de Ciencias Médicas de la Universidad de Cuenca

Section

Policy briefs

License

Copyright (c) 2024 Bernardo Vega Crespo, Vivian Alejandra Neira Molina , Andrés Andrade Galarza , Dayanara Delgado López , Veronique Verhoeven , Miguel Rodríguez Jiménez

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright © Autors.

You are free to:

Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Under the following conditions:

Attribution — You must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licenser endorses you or your use.
  NonCommercial  — You may not use the material for commercial purposes.
  ShareAlike  — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the licence permits.